NK cell-based cancer immunotherapy: from basic biology to clinical development
S Liu, V Galat, Y Galat4, YKA Lee… - Journal of hematology & …, 2021 - Springer
Natural killer (NK) cell is a specialized immune effector cell type that plays a critical role in
immune activation against abnormal cells. Different from events required for T cell activation …
immune activation against abnormal cells. Different from events required for T cell activation …
CAR-NK cells for cancer immunotherapy: from bench to bedside
L Zhang, Y Meng, X Feng, Z Han - Biomarker Research, 2022 - Springer
Natural killer (NK) cells are unique innate immune cells and manifest rapid and potent
cytotoxicity for cancer immunotherapy and pathogen removal without the requirement of …
cytotoxicity for cancer immunotherapy and pathogen removal without the requirement of …
Induced pluripotent stem cells in disease modelling and drug discovery
The derivation of induced pluripotent stem cells (iPSCs) over a decade ago sparked
widespread enthusiasm for the development of new models of human disease, enhanced …
widespread enthusiasm for the development of new models of human disease, enhanced …
[HTML][HTML] Human iPSC-derived natural killer cells engineered with chimeric antigen receptors enhance anti-tumor activity
Chimeric antigen receptors (CARs) significantly enhance the anti-tumor activity of immune
effector cells. Although most studies have evaluated CAR expression in T cells, here we …
effector cells. Although most studies have evaluated CAR expression in T cells, here we …
Pluripotent stem cell–derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity
H Zhu, RH Blum, R Bjordahl… - Blood, The Journal …, 2020 - ashpublications.org
Antibody-dependent cellular cytotoxicity (ADCC) is a key effector mechanism of natural killer
(NK) cells that is mediated by therapeutic monoclonal antibodies (mAbs). This process is …
(NK) cells that is mediated by therapeutic monoclonal antibodies (mAbs). This process is …
[HTML][HTML] CAR-NK for tumor immunotherapy: Clinical transformation and future prospects
W Wang, J Jiang, C Wu - Cancer letters, 2020 - Elsevier
Recently, the use of chimeric antigen receptor-modified T (CAR-T)-cells in the treatment of
hematological tumors has been successful and has become a clinical hotspot in tumor …
hematological tumors has been successful and has become a clinical hotspot in tumor …
Chimeric antigen receptor expressing natural killer cells for the immunotherapy of cancer
RS Mehta, K Rezvani - Frontiers in immunology, 2018 - frontiersin.org
Adoptive cell therapy has emerged as a powerful treatment for advanced cancers resistant
to conventional agents. Most notable are the remarkable responses seen in patients …
to conventional agents. Most notable are the remarkable responses seen in patients …
Latency reversal plus natural killer cells diminish HIV reservoir in vivo
JT Kim, TH Zhang, C Carmona, B Lee, CS Seet… - Nature …, 2022 - nature.com
HIV is difficult to eradicate due to the persistence of a long-lived reservoir of latently infected
cells. Previous studies have shown that natural killer cells are important to inhibiting HIV …
cells. Previous studies have shown that natural killer cells are important to inhibiting HIV …
CAR‐NK cells: the next wave of cellular therapy for cancer
T cells engineered to express chimeric antigen receptors (CARs) have revolutionised the
field of cellular therapy for cancer. Despite its success, this strategy has some recognised …
field of cellular therapy for cancer. Despite its success, this strategy has some recognised …
Advantages and applications of CAR-expressing natural killer cells
W Glienke, R Esser, C Priesner, JD Suerth… - Frontiers in …, 2015 - frontiersin.org
In contrast to donor T cells, natural killer (NK) cells are known to mediate anti-cancer effects
without the risk of inducing graft-versus-host disease (GvHD). In order to improve cytotoxicity …
without the risk of inducing graft-versus-host disease (GvHD). In order to improve cytotoxicity …